Related Experiment Video
Updated: Jan 29, 2026

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
Published on: August 2, 2018
α-Methyl-prednisolone normalizes the PKC mediated brain angiogenesis in dystrophic mdx mice
Tiziana Annese1, Simona Ruggieri1, Michela De Giorgis1
1Department of Basic Medical Sciences, Neurosciences and Sensory Organs, Section of Human Anatomy and Histology, University of Bari Medical School Bari, University of Bari, Italy.
Abstract:
A fraction of patients affected by Duchenne Muscular Dystrophy (DMD) shows mental disability as a consequence of neuronal and metabolic alteration. In this study, we evaluated the effect of α-methyl-prednisolone (PDN) on the expression of the angiogenic marker HIF1α, VEGFA and VEGFR-2 (FLK1) in correlation with PKC expression in the brain of mdx mouse, an experimental model of DMD. We demonstrated that HIF1α, VEGFA and FLK1 are overexpressed in the brain of dystrophic mdx mice in parallel with an increase of PKC expression and reduction of the tight junctions Occludin leading to altered angiogenesis. Moreover, we demonstrated that PDN treatment induces a significant reduction in the HIF1α, VEGF, FLK1, and PKC mRNA and proteins levels and restores Occludin expression reducing its phosphorylation pattern. Our results suggest a new mechanism of action of PDN that through PKC suppression normalizes the angiogenesis in dystrophic mdx brains.
Insights
Duchenne Muscular Dystrophy (DMD) brains show altered angiogenesis due to increased protein kinase C (PKC) and reduced tight junctions. Alpha-methyl-prednisolone (PDN) treatment normalized these factors, suggesting a new therapeutic mechanism for DMD.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Duchenne Muscular Dystrophy (DMD) can cause mental disability linked to neuronal and metabolic changes.
- Altered angiogenesis and brain vascularization are implicated in DMD pathophysiology.
Purpose of the Study:
- To investigate the effect of alpha-methyl-prednisolone (PDN) on angiogenic markers (HIF1α, VEGFA, VEGFR-2/FLK1) and protein kinase C (PKC) in the mdx mouse model of DMD.
- To explore PDN's impact on brain tight junctions, specifically Occludin, in the context of DMD.
Main Methods:
- Utilized the mdx mouse model, an established experimental model for Duchenne Muscular Dystrophy.
- Quantified mRNA and protein levels of HIF1α, VEGFA, FLK1, PKC, and Occludin.
- Assessed Occludin phosphorylation to evaluate tight junction integrity.
Main Results:
- mdx mice exhibited overexpression of HIF1α, VEGFA, and FLK1, alongside increased PKC and reduced Occludin expression, indicating altered brain angiogenesis.
- PDN treatment significantly decreased HIF1α, VEGF, FLK1, and PKC levels (mRNA and protein).
- PDN administration restored Occludin expression and reduced its phosphorylation, suggesting improved tight junction function.
Conclusions:
- PDN normalizes aberrant angiogenesis in the brains of mdx mice by suppressing PKC signaling.
- This study reveals a novel mechanism of action for PDN in potentially mitigating neurological aspects of DMD.
Related Concept Videos
Mechanism of Angiogenesis
Normal Stress
When a rod is under axial loading, the internal forces and corresponding stress are normal to the plane of the section, so it is termed normal stress. It's important to...
Normal Distribution
Normal and Shear Force
Applications of Normal Distribution
The heights of 15 to 18-year-old males from Chile from 1984 to 1985 followed a normal distribution. The mean height is 172.36...
Introduction to Normal Distributions

